UTHR
United Therapeutics Corp

2,467
Mkt Cap
$37.77B
Volume
544,886.00
52W High
$548.12
52W Low
$266.98
PE Ratio
19.22
UTHR Fundamentals
Price
$536.12
Prev Close
$532.82
Open
$533.83
50D MA
$487.58
Beta
0.46
Avg. Volume
376,933.71
EPS (Annual)
$27.86
P/B
3.30
Rev/Employee
$2.27M
$20,418.98
Loading...
Loading...

About

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,400

Frequently Asked Questions

What is Market Cap of United Therapeutics Corp?
What is the 52-week high for United Therapeutics Corp?
What is the 52-week low for United Therapeutics Corp?
What is United Therapeutics Corp stock price today?
What was United Therapeutics Corp stock price yesterday?
What is the PE ratio of United Therapeutics Corp?
What is the Price-to-Book ratio of United Therapeutics Corp?
What is the 50-day moving average of United Therapeutics Corp?
How many employees does United Therapeutics Corp have?

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.